AntriaBio Acquires Assets of PR Pharmaceuticals, Inc. and Announces Intent to Merge With a Public Company
1/7/2013 10:24:42 AM
More...
|
SurModics Inc. (SRDX) Acquires Drug Delivery Assets of PR Pharmaceuticals, Inc.
11/5/2008 6:55:50 AM
More...
|
Jerini Ophthalmic and PR Pharmaceuticals, Inc. Sign Collaboration Agreement to Develop Sustained-Release Formulations for the Treatment of Eye Diseases
4/10/2008 2:54:41 PM
More...
|
PR Pharmaceuticals, Inc. Announces Initiation Of A Phase I Study Of A New Potential Treatment For Pulmonary Arterial Hypertension
3/28/2006 11:02:40 AM
More...
|
PR Pharmaceuticals, Inc. Release: New Patent Issued To The University of Pittsburgh For 2-Methoxyestradiol
3/16/2006 11:10:16 AM
More...
|
PR Pharmaceuticals, Inc. Announces Collaboration With OSI Pharmaceuticals, Inc. (OSIP) To Develop Sustained Release Formulation Of Macugen(R)
1/11/2006 10:24:10 AM
More...
|
PR Pharmaceuticals, Inc. Files IND For Pulmonary Hypertension
12/20/2005 10:36:52 AM
More...
|
PR Pharmaceuticals, Inc.'s PulmoLAR(TM) Granted Orphan Drug Status
10/19/2005 5:10:15 PM
More...
|